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Abstract
Osteoporosis is associated with chronic iron overload secondary to hereditary hemochro-
matosis (HH), but the causative mechanisms are incompletely understood. The main objec-
tive of this study was to investigate the role of dietary iron on osteoporosis, using as
biological model the Hfe-KO mice, which have a systemic iron overload. We showed that
these mice show an increased susceptibility for developing a bone loss phenotype com-
pared to WT mice, which can be exacerbated by an iron rich diet. The dietary iron overload
caused an increase in inflammation and iron incorporation within the trabecular bone in both
WT and Hfe-KO mice. However, the osteoporotic phenotype was only evident in Hfe-KO
mice fed the iron-enriched diet. This appeared to result from an imbalance between bone
formation and bone resorption driven by iron toxicity associated to Hfe-KO and confirmed by
a decrease in bone microarchitecture parameters (identified by micro-CT) and osteoblast
number. These findings were supported by the observed downregulation of bone metabo-
lism markers and upregulation of ferritin heavy polypeptide 1 (Fth1) and transferrin receptor-
1 (Tfrc), which are associated with iron toxicity and bone loss phenotype. In WT mice the
iron rich diet was not enough to promote a bone loss phenotype, essentially due to the con-
comitant depression of bone resorption observed in those animals. In conclusion the dietary
challenge influences the development of osteoporosis in the HH mice model thus suggest-
ing that the iron content in the diet may influence the osteoporotic phenotype in systemic
iron overload conditions.
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Introduction
Iron is one of the most important minerals in biological systems, with relevant roles in oxygen
transport, energy production, DNA synthesis and regulation of several enzymes [1–3]. When
in excess, iron contributes to the development of several diseases such as liver cirrhosis, hepa-
tocarcinoma, cardiac cirrhosis, diabetes mellitus, osteoarthritis and osteoporosis [4,5]. Heredi-
tary hemochromatosis (HH) is a genetic disorder characterized by systemic iron overload due
to hepcidin (HAMP) deficiency [3,5]. The majority of HH cases (~80%) have been associated
with mutations in Human Hemochromatosis protein (HFE) gene, essentially C282Y, with a
prevalence of 1:200 to 1:300 in populations with northern European ancestry [4,6]. HFE can
regulate intracellular iron entry by competing with Transferrin (TF) for Transferrin Receptor
1 (TFRC) binding and when mutated it affects HAMP expression negatively [4,6].
Osteoporosis (OP) has been associated to HH and iron overload [7–10]. A significant per-
centage of HH patients develop low bone mass (74–79%), eventually resulting in OP (25–34%)
that worsens with age [9,10]. HH-related OP results from the imbalance between bone forma-
tion and resorption leading to deterioration of bone microarchitecture and increased fracture
risk [2,9,11]. OP onset and progression are subject to synergistic factors, such as a decrease in
levels of estrogen and progesterone in postmenopausal women, associated with iron overload
and oxidative stress [2,11]. Nutrition is also an important variable in OP pathophysiology
since a disruption of the nutritional equilibrium of several essential minerals, like Cu, Fe, Mg
and Zn, as well as iron overload associated with diet and age, have been described as factors
that can contribute to OP [8,12,13].
A preliminary evaluation of bone microarchitecture in a murine model of HH performed
in our laboratory showed incomplete penetration of bone loss phenotype (Fig A in S1 File),
suggesting that other variables could contribute to the development of HH-related osteoporo-
sis. Therefore, the aim of this study was to determine if, by providing a supplementary dietary
iron intake, we could promote the development of an osteoporotic phenotype.
Material and methods
All chemical reagents described in this section were obtained from Sigma-Aldrich unless stated
otherwise.
Ethical statement
All the individuals involved in animal handling and experimentation received proper training
(category B courses accredited by FELASA, the Federation of Laboratory Animal Science
Associations). All experimental procedures involving animals followed the European Directive
2010/63/EU and the related guidelines (European Commission, 2014). The animal experi-
ments were performed on the animal facility of the Institute for Molecular and Cell Biology
(IBMC), University of Porto, Portugal, which was licensed by Portuguese National Authority
for Animal Health (DGAV) on October 23rd of 1999, according with articles 27th and 36th of
ministerial decreed n˚ 1005/92 of Portuguese legislation (Decreto-Lei 113/2013) for animal
experimentation and welfare. In addition, experiments were authorized by the Institute for
Molecular and Cell Biology’s animal ethics committee.
Biological model
The murine model of HH used in this study, Hfe-KO in a C57BL/6 background, was described
by Bahram et al. (1999) [14] and backcrossed with C57BL/6 mice colony at IBMC. The Hfe-
KO mice are homozygotes for a removal of exons 2 and 3 of the HFE gene, leading to loss of
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function of the HFE protein [14,15]. All mice were maintained at the IBMC animal facility
kept in a 12hrs light/dark cycle, in specific pathogen-free conditions, and had ad libitum access
to water and food (standard diet-Harlan 2018S, Teklad Global Rodent Diets, iron content 200
mg/kg) from the time of weaning until sacrifice.
Experimental design
A total of 24 male mice, 12 Hfe-KO and 12 WT, were used in this study. Since weaning and
until the completion of 3 months of age the animals were fed with the standard diet. Between 3
and 6 months of age, 6 animals of each strain were fed with an iron-enriched diet (Harlan
2018S supplemented with 1% of iron carbonyl) while the remaining animals were kept on the
standard diet until they completed 6 months of age. At this time the mice were anesthetized
with a combination of ketamine (1mg/10g body weight, i.p., Merial), xylazine (0.1mg/10g
body weight, i.p., Bayer) and acepromazine (0.03mg/10g body weight, i.p., Ve´toquinol) and
sacrificed. The hindlimbs were collected and prepared for the different analyses, the right hin-
dlimb for histological, histomorphometric and micro-CT analysis and the left hindlimb for
total RNA isolation.
One animal from WT group under control diet (C) died and was excluded from this study
because it showed signs of fragility and disease which compromised the animal welfare. After
animal identification, it was anesthetized accordingly with described previously and sacrificed
by cervical dislocation. The final distribution of animals by groups was the following: Hfe-KO
with control diet (KO): 6 mice, Hfe-KO with iron-enriched diet (KO+I): 6 mice; WT with con-
trol diet (C): 5 mice; WT with iron-enriched diet (C+I): 6 mice.
Quantification of iron biochemical parameters in serum
Blood was collected by intra-cardiac puncture to tubes containing Heparin-Lithium and sent
to an external certified commercial laboratory (DNAtech, Lisbon, Portugal) for determination
of serum iron, serum ferritin and serum transferrin saturation similar to what was described
previously [16].
Micro computed tomography (micro-CT)
Bone microarchitecture was always assessed using the right hindlimb of each mouse. The sam-
ples were fixed for 24h with 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS)
at pH7.4 and preserved in 70% ethanol until data acquisition by micro-CT with a Skyscan
1272 X-ray computed microtomography (Bruker, Belgium). Samples were wrapped in labora-
tory film (Parafilm), embedded in distilled water and placed inside 2mL tubes (Sarstedt). For
image acquisition, the following parameters were used: X-ray tube potential 70 kV, X-ray tube
current 142 μA, 0.5mm Al filter, rotation step 0.4˚, isotropic voxel size 5 μm3 and exposure
time 1500ms. For data reconstruction, the NRecon software (v1.6.9.8, Bruker, Belgium) was
used, with Gaussian smoothing, ring artefact correction and 40% beam hardening correction
applied. Using Dataviewer software (v1.4.4, Bruker, Belgium) each dataset was normalized
regarding its orientation and saved in trans axial (X-Y) projections, and then exported to
CTAn software (v1.13.11.0, Bruker, Belgium). To measure bone microarchitecture parameters
for each dataset, growth plate plus 0.25mm was used as structural reference between each sam-
ple and then, using CTAn software, the regions of interest (ROI) for 1.2mm in length were
selected and three-dimensional microarchitecture parameters calculated for both the femur
and tibia and expressed according with the ASBMR recommendations [17]. Microarchitecture
parameters included bone volume fraction (BV/TV), bone volume (BV), trabecular thickness
(Tb.Th), trabecular number (Tb.N), trabecular separation (Tb.Sp), and structural model index
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(SMI), indicative of trabecular organization [18]. Three-dimensional reconstructions repre-
sentative of bone status evaluation in femur and tibia were done with CTvox software (v3.1.1,
Bruker, Belgium).
Histomorphometric analysis
After micro-CT analysis, femurs were included in methyl methacrylate (MMA) at 4˚C. Serial
5μm sections were cut in three distinct levels, eight sections per level, with a 50μm interval
between levels. Relative osteoid surface (Osteoid / Bone surfaces = OS/BS �100%) and number
of osteoblast per bone surface N.Ob/BS (mm-1) were determined in 2 sections per level in each
animal by staining with toluidine blue (1%) as described previously [19]. The Axioimager Z2
microscope (Zeiss, Germany) was used for osteoid and bone surfaces identification and each
area was measured with Axiovision software (Zeiss, Germany) at 200x magnification. Bone
and osteoid surfaces were measured in the distal metaphysis of the femur. To determine the
osteoblasts number (N.Ob) in OS a magnification of 400x was used (Axioimager Z2 micro-
scope, Zeiss, Germany). Osteoclasts were stained with naphthol AS-TR (3- hydroxy-
2-naphthoic acid 4-chloro-2-methylanilide) phosphate for tartrate-resistant acid phosphatase
(TRAP) detection and counterstained with Toluidine blue (0.5%), [20]. Osteoclasts were
counted and expressed relatively to bone surface as Oc.S/B.Ar (mm2). To evaluate total iron
accumulation in femur trabecular bone, sections were stained with Perl’s solution ((2% Ferro-
cyanide potassium) 1:1 (2% HCl (37%)) and counterstained with Nuclear Fast Red (1%).
Expression of bone tissue markers in tibia
RNA extraction of bones derived from the left hindlimb of both WT and Hfe-KO mice for
each condition tested (C, C+I, KO and KO+I), was done with Isol-RNA Lysis Reagent (5
Prime-VWR) according with the manufacture instructions, followed by RNA purification
with GeneJET RNA purification Kit (Thermo-Scientific). RNA samples were quantified and
assessed for purity using a Nanodrop 2000 (Thermo Scientific). RNA integrity was evaluated
by Experion system (Bio-Rad) and then 1μg of RNA for each condition was submitted to
DNase treatment (Promega) and reverse transcribed using 1μL of oligo(dT) adapter primer
(10μM) and 1μL of M-MLV Reverse Transcriptase (1U/μL, Invitrogen), following the manu-
facture instructions. The real-time polymerase chain reaction (qPCR), (20μl) was performed
using as template 2μl of 1:10 cDNA dilution for each condition tested, 10μl of SsoFast Eva-
green Taq supermix (BioRad), 0.6 μl of primers for target genes or housekeeping genes
(300nM), (Table A in S1 File) and the final volume completed with purified water free from
RNases (Sigma). Amplification by qPCR was performed in a CFX96 System (Bio-Rad) in three
independent qPCR reactions for each sample. To determine the levels of gene expression all
results were normalized to levels of expression of Glyceraldehyde-3-Phosphate Dehydrogenase
(Gapdh) and relative expression was determined by the ΔΔCt method[21] using the condition
C (WT with standard diet) as control group for basal expression (1).
Statistical analysis
The results are expressed as group means and associated mean standard error (SEM). Each
group was evaluated for normality with Kolmogorov-Smirnov test and confirmed for applica-
tion of parametric analysis. Analysis for the impact of iron rich diet on serum iron parameters,
bone microarchitecture, bone histomorphometric parameters and gene expression were done
by comparison with T-test (Welch’s correction) between control diet and iron rich diet groups
within each genotype, (C vs C+I and KO vs KO+I) with p<0.05 for statistical significance. The
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correlation between Trap positive cells/bone surface and bone microarchitecture parameters
was done by Pearson method with p<0.05 for significance.
Results
Increased systemic and bone iron accumulation in Hfe-KO mice
In the absence of an iron enriched diet, Hfe-KO mice presented already an increase in serum
iron concentration (+54.6%) and transferrin saturation (Trf Sat; +84.6%), when compared to
normal levels observed into WT (Fig 1), reflecting the disruption of normal iron metabolism
already present in KO mice as a consequence of the Hfe loss of function. Once fed with an iron
enriched diet, these levels suffered a further increase in KO mice, but the most important
being observed in the serum ferritin levels, which increased 503.2%, reflecting a likely increase
in total iron accumulation in tissues. In WT controls, all three parameters analyzed increased
also when the animals were given the iron enriched diet, approaching the levels observed in
KO animals fed the same diet for circulating levels of iron and transferrin saturation, while
their levels of serum ferritin increased but remained much lower than those of the KO+I
group. Therefore, serum ferritin appeared to be the most sensitive parameter responding to
iron overload under the experimental conditions used.
The levels of iron accumulation on the surface of bone trabeculae, evaluated by Perls stain-
ing, showed a clear difference between [C] and [KO] groups, with the latter presenting an
Fig 1. Evaluation of systemic iron accumulation in blood serum and bone. In blood serum: a) Total iron concentration; b) Transferrin saturation; c) Total
concentration of serum ferritin. In bone: d) Detection of iron deposits (stained in blue) in femur bone trabeculae and bone marrow through Perls staining. Each
group analyzed was composed by n = 6 animals for [C+I], [KO] and [KO+I], and by n = 5 for [C]. Statistical comparison was performed with T-test (Welch’s
correction) between control and iron-enriched diets for both WT ([C] and [C+I]]) and Hfe-KO mice ([KO] and [KO+I])). Group deviations are expressed as
standard error to the mean (SEM). Statistical significance: (�)-p<0.05; (��)-p<0.01; (����)-p<0.0001.
https://doi.org/10.1371/journal.pone.0207441.g001
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increase in iron accumulation on the surface of trabeculae together with an increase of iron
deposits in bone marrow (Fig 1D). The feeding of an iron-enriched diet to [C+I] and [KO+I]
groups led to a further increase in iron accumulation in the bone marrow (Fig 1D). However,
[KO+I] showed a thicker layer of iron deposits on bone surface and clearly increased areas of
iron deposits embedded in bone matrix as compared to their C+I controls, being more evident
than in the KO animals that did not feed on an iron enriched diet (Fig 1D).
Molecular response to iron overload, oxidative stress and inflammation in
bone tissue of mice subjected to iron-enriched diet
Gene expression analysis of iron metabolism markers showed that the iron-enriched diet only
promoted significant changes in Hfe-KO mice ([KO+I]), with increase in the expression of fer-
ritin heavy polypeptide 1 (Fth1) and transferrin receptor-1 (Tfrc) (Fig 2A), while there were no
significant changes in ferroportin (Slc40a1) expression.
The iron-enriched diet also promoted an increased expression of catalase (Cat) in both
groups ([C+I] and [KO+I]) (Fig 2B). To determine the impact of iron-enriched diets on
inflammation we evaluated the expression of tumor necrosis factor (Tnf) and interleukin 6
(Il6) in all groups. There appeared to be a consistent increase in both groups under the iron
enriched diet, although only clearly significant for the expression of Il6 in the WT and for the
Tnf in the Hfe-KO mice (Fig 2C) suggesting that the dietary iron overload promoted
inflammation.
Fig 2. Gene expression analysis of iron metabolism, oxidative stress and inflammation markers in bone tissue. a) Iron metabolism: ferroportin
(Slc40a1), ferritin heavy polypeptide 1 (Fth1) and transferrin receptor 1 (Tfrc). b) Oxidative stress: catalase (Cat). c) Inflammation response: Tumor
necrosis factor (Tnf) and Interleukin 6 (Il6). Relative expression was obtained through ΔΔCt method and was normalized with Gapdh. Each group analyzed
was composed by n = 6 animals for [C+I], [KO] and [KO+I], and by n = 5 for [C]. Statistical comparison was performed with T-test (Welch’s correction)
between control and iron-enriched diets for both WT ([C] and [C+I]]) and Hfe-KO mice ([KO] and [KO+I])). Group deviations are expressed as standard
error to the mean (SEM). Statistical significance: (�)-p<0.05; (��)-p<0.01; (���)-p<0.001.
https://doi.org/10.1371/journal.pone.0207441.g002
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Iron-enriched diet accelerated bone loss in Hfe-KO mice
Iron-enriched diet had different impacts on femur microarchitecture parameters for WT and
Hfe-KO mice. In the [C+I] group there was an increase in BV/TV and Tb.N relatively to [C]
which suggest an increase in trabecular bone (Fig 3). In contrast, the results from the [KO+I]
group showed a decrease in BV, BV/TV and Tb.N when compared to [KO], while Tb.Sp and
SMI were increased (Fig 3). These results were confirmed by the analysis of tibia micro-CT
microarchitecture parameters and femur microarchitecture bidimensional analysis by Anilline
blue staining.
Representative images of bone microarchitecture for each group can be observed in tri-
dimensional reconstructions of femur and tibia trabecular bone (Fig 4). This data suggests
that, in contrast to WT mice, dietary iron supplementation has a deleterious effect on bone
metabolism in Hfe-KO mice, in agreement with the microarchitecture parameters measured
in the same animals.
Iron-enriched diet contributes to decreased bone formation
To determine the impact of dietary iron supplementation on bone formation and mineraliza-
tion, the relative osteoid surface (OS/BS) and number of osteoblasts per bone surface (N.Ob/
BS) were evaluated, as well as the expression of markers associated with bone formation. The
results show that both OS/BS and N.Ob/BS were statistically decreased in the Hfe-KO mice
Fig 3. Evaluation of bone microarchitecture status by micro-Ct. Analysis of bone status was performed by determining microarchitecture parameters
of bone volume fraction (BV/TV), bone volume (BV), trabecular thickness (Tb.Th), trabecular number (Tb.N), trabecular separation (Tb.Sp), and
structural model index (SMI). Each group analyzed was composed by n = 6 animals for [C+I], [KO] and [KO+I], and n = 5 for [C]. Statistical
comparison was performed with T-test (Welch’s correction) between control and iron-enriched diets for both WT ([C] and [C+I]]) and Hfe-KO mice
([KO] and [KO+I])). Group deviations are expressed as standard error to the mean (SEM). Statistical significance: (�)-p<0.05; (��)-p<0.01;
(����)-p<0.0001.
https://doi.org/10.1371/journal.pone.0207441.g003
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subjected to iron-enriched diet (Fig 5A), thus confirming a decrease in bone formation in this
group, consistent with the results obtained by micro-CT analysis.
Analysis of the molecular markers for bone formation and mineralization showed a
decrease for osteocalcin-2 (Bglap2), lactoferrin (Ltf) and sclerostin (Sost) expression in WT
and Hfe-KO mice subjected to iron-enriched diets (Fig 5), consistent with a decrease in bone
formation in the presence of iron overload. However, expression of runt related transcription
factor 2 (Runx2), which is associated with early osteoblast differentiation, presented either no
significant changes or only a moderate increase of expression in response to iron-enriched diet
in both groups fed an iron enriched diet.
Iron-enriched diet promotes a decrease in osteoclast number and activity
preventing a deleterious effect on bone microarchitecture in WT mice
In the presence of iron-enriched diet, the number of Trap positive cells per bone surface was
significantly decreased in WT animals ([C+I]), associated with a clear downregulation of the
expression of tartrate-resistant acid phosphatase type 5 (Acp5) (Fig 6A). The iron overload-
related decrease in number and activity of osteoclasts resulted in less resorption and thus an
increase in bone mass, explaining the observed increase in BV/TV obtained from the micro-
CT parameters. In contrast, both parameters appeared to be increased in the KO mice under
an iron rich diet, despite being at the limit of significance, consistent once again with the
micro-CT data
Evaluation of the correlation between N.Oc/B.Ar relatively to Tb.N, Tb.Sp and SMI showed
a statistical significant linear correlation between N.Oc/B.Ar and Tb.N (p<0.0014), Tb.Sp
(p<0.0150) and SMI (p<0.0280), with negative correlation for Tb.N and positive correlation
to Tb.Sp and SMI, (Fig 6B). The correlation between osteoclast number/bone surface and
bone microarchitecture parameters is consistent with the phenotypes observed in WT and
Hfe-KO mice fed with the iron-enriched diets. In addition, [C+I] mice revealed significant
downregulation of bone morphogenetic proteins 2 (Bmp2) and 6 (Bmp6) and parathyroid hor-
mone 1 receptor (Pthr) relatively to [C] (Fig 7), which was not observed in Hfe-KO subject to
Fig 4. Micro-CT scans showing bone status from femur and tibia. Evaluation of microarchitecture parameters following three-dimensional reconstructions
from micro-CT scans of femur and tibia as described previously. Three-dimensional reconstructions were obtained from femur and joint scans and from tibia
trabecular bone scans using CTvox software (v3.1.1, Bruker, Belgium). Images scale bars equivalence: Femur and joint- 150μm, Tibia trabeculae- 100μm.
https://doi.org/10.1371/journal.pone.0207441.g004
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iron rich diet (Fig 7). Altogether the results obtained are in agreement with a repression of
osteoclastogenesis in [C+I] but not in [KO+I] mice.
Discussion
To study the effects of dietary iron supplementation on bone metabolism and which molecular
mechanisms could be involved on the onset and progression of OP phenotype, we have used
an HH biological model for systemic iron overload, the Hfe-KO mouse [14], and evaluated its
bone status when subjected to two different diets, standard (200 mg/Kg of Fe) and iron-
enriched (200mg/Kg of Fe plus 1% iron carbonyl relatively to total ratio weight). In a parallel
experiment a similar dietary treatment was given to WT mice to evaluate their response to
iron overload in the absence of Hfe mutations. The iron-enriched diet led to an osteoporotic
phenotype only on the Hfe-KO animals while in WT mice it led to an increase in BV/TV most
likely by a repression of osteoclastogenesis, not observed in the Hfe-KO.
The dietary iron supplementation caused systemic iron overload on both WT and Hfe-KO
mice, as described previously [22–25]. [C+I] and [KO+I] mice also showed abnormal elevation
of serum ferritin concentrations (Fig 1C), which suggested a significant increase in total body
iron stores associated with signs of inflammation, as described for HH patients [26] and also
observed in similar studies associated with iron carbonyl supplementation [24]. In addition,
increased iron accumulation in trabecular bone was observed for [KO], [C+I] and [KO+I]
Fig 5. Impact of iron overload on bone formation. a) Evaluation of osteoid surface (OS/BS) and number of osteoblast (N.Ob/BS). b) Gene expression of bone
formation markers: osteocalcin (Bglap2), lactoferrin (Ltf), sclerostin (Sost) and runt related transcription factor 2 (Runx2). Relative expression was obtained by
ΔΔCt method and was normalized with Gapdh. Each group analyzed was composed by n = 6 animals for [C+I], [KO] and [KO+I], and by n = 5, for [C].
Statistical comparison was performed with T-test (Welch’s correction) between control and iron-enriched diets for both WT ([C] and [C+I]]) and Hfe-KO mice
([KO] and [KO+I])). Group deviations are expressed as standard error to the mean (SEM). Statistical significance: (�)-p<0.05; (��)-p<0.01; (���)-p<0.001.
https://doi.org/10.1371/journal.pone.0207441.g005
Iron-enriched diet contributes to early onset of osteoporotic phenotype in Hfe-KO mouse
PLOS ONE | https://doi.org/10.1371/journal.pone.0207441 November 14, 2018 9 / 16
mice, in agreement with previous works [25,27]. In [C] group, iron deposits were only detected
on bone marrow (Fig 1D) but following dietary iron overload ([C+I]), iron deposits were also
found in bone marrow and skeletal tissue, but mainly in the osteoid. In contrast, in [KO]
group a severe iron accumulation was already observed even in the absence of dietary iron
overload, because of the systemic increase in iron due to Hfe mutation, with iron deposits
already present on bone surface as well as in osteoid (Fig -d). These results were even more evi-
dent in the [KO+I] group, with iron deposits also found within bone mineralized matrix (Fig
1D) indicating that Hfe-KO mice are more susceptible to iron overload, a result also in agree-
ment with our previous data (Fig A in S1 File.).
Bone loss was accelerated in [KO+I], with significant decrease on bone formation parame-
ters such as relative osteoid surface and osteoblasts number per bone surface (Fig 5A). In addi-
tion, bone formation markers like Bglap2, Ltf and Sost were downregulated (Fig 5B), in
agreement with the histomorphometric results observed in the same mice (Fig 3), thus con-
firming a negative effect of the iron-enriched diet in bone metabolism. These results are also in
agreement with previous studies [25,28,29]. Together, these results suggested that osteoblast
death and mineralization impairment could represent also inhibition of osteoblast differentia-
tion as described in vitro previously [30]. However Runx2 was upregulated in [KO+I] group
which could be explained by the significant downregulation of Sost (Fig 5B), which is known
to inhibit WNT signaling by interacting with Low density lipoprotein receptor-related protein
Fig 6. Trap positive cells per bone surface and correlation with trabecular bone microarchitecture. a) Number of trap positive cells per trabeculae surface
and relative expression of acid phosphatase 5, tartrate resistant (Acp5) obtained by ΔΔCt method normalized with Gapdh. Each group analyzed was composed
by n = 6 animals for [C+I], [KO] and [KO+I], and by n = 5, for [C]. b) Correlation between number of osteoclasts per trabeculae surface with Tb.N, Tb.Sp and
SMI. Correlation was determined through Pearson’s test, with significance of p<0.05. Dashed line identifies confidence interval (95%). Statistical comparison
with T-test (Welch’s correction) between control and iron-enriched diets for both WT ([C] and [C+I]]) and Hfe-KO mice ([KO] and [KO+I])). Group
deviations are expressed as standard error to the mean (SEM). Statistical significance: (�)-p<0.05.
https://doi.org/10.1371/journal.pone.0207441.g006
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5 (LRP5) [31]. And attending that WNT signaling is important for RUNX2 induction [32,33],
results obtained suggest that downregulation of Sost could lead to an increase in WNT path-
way and thus favor Runx2 upregulation in the context of this experiment. Furthermore, those
results suggest a mechanism to compensate bone loss promoted by iron overload which can
lead to osteoblast differentiation and recruiting. Nevertheless, this is not dismissive of the pos-
sible negative impact of iron overload on osteoblast differentiation as shown by significant
downregulation of Bglap2 and decrease in osteoblast number, which could be the result of the
associated iron toxicity on mature and immature osteoblasts and osteocytes. Altogether, these
results suggest the uncoupling between bone formation and resorption mechanisms.
Fig 7. Gene expression of markers associated with regulation of bone metabolism. Relative expression: a) bone morphogenic protein 6 (Bmp6); b) Bone
morphogenic protein 2 (Bmp2); c) Sp7 transcription factor 7 (Sp7); d) Parathyroid hormone 1 receptor (Pthr). Expression was determined by ΔΔCt method and
normalized with Gapdh. Each group was composed by n = 6 animals ([C+I], [KO] and [KO+I]) except for [C] (n = 5). Comparison among groups was done by unpaired
t-student test with Welch’s correction and significance of p<0.05. Group deviations are expressed as standard error to the mean (SEM). Statistical significance: (�) =
p<0.05.
https://doi.org/10.1371/journal.pone.0207441.g007
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The abovementioned uncoupling between bone formation and resorption was only evident
in mice Hfe KO subject to iron rich diet and the analysis of iron metabolism markers revealed
the impact of the conjugation between enriched diet and Hfe loss of function, resulting in an
upregulation of Fth1 and Tfrc in the [KO+I] group (Fig 2A). Increased expression of these
genes has been associated with bone loss phenotypes, with ferritin ferroxidase activity previ-
ously shown to inhibit calcium deposition and osteocalcin expression [30,34], while upregula-
tion of Tfrc, previously observed in bone tissue, was suggested to facilitate iron accumulation
associated with bone loss [28]. Fth1 and Tfrc have been shown to be regulated by increased
iron concentrations at post-transcription level by the presence of iron response elements
(IREs) which can be recognized by Iron response proteins (IRPs) 1 and 2 [28]. Usually, upon
high iron concentrations, Fht1 mRNA expression is not affected but translation is increased
while translation of Tfrc is decreased due to mRNA destabilization by absence of IRP’s avail-
ability for binding to its 3’ UTR IRE’s due to competition with high intracellular iron concen-
trations [28]. In contrast, if a ferroptosis mechanism is triggered, this can lead to the
upregulation of both Fth1 [35] and Tfrc [36] in order to induce cell death. Ferroptosis is a
mechanism of programmed cell death which uses iron as cofactor when cells cannot regulate
high levels of oxidative stress [37,38]. Indeed, Fth1 can be also upregulated by increased levels
of oxidative stress in order to decrease intracellular iron labile concentrations and avoid for-
mation of ROS [39], to which we can add the upregulation of Cat and Tnf (Fig 2C), already
known to be increased in response to oxidative stress [40].
Since [KO+I] group showed upregulation of Cat and Tnf (Fig 2C), which also favors osteo-
clastogenesis [41–43], this contributes to explain the uncoupling of bone metabolism (i) by the
increase of osteoclast activity, as shown by an increase in Acp5 expression and number of Trap
positive cells relatively to [KO] group (Fig 6A), and (ii) by promoting osteoblast death [44], as
shown by the decrease in osteoblast number detected (Fig 5A). Together, these evidences sug-
gest that ferroptosis could be a mechanism associated to bone loss in [KO+I]. In addition, the
absence of statistically significant changes in Slc40a1 expression may reflect the inability of
bone cells to export iron to alleviate intracellular iron toxicity.
Evidences of iron overload conditions were also observed in [C+I] group (Fig 1), however
there were no significant changes in Fth1 and Tfrc expression (Fig 2), as well as no significant
changes in the number of osteoblasts in their bones indicating that, despite the fact that [C+I]
showed some evidences of bone loss, as shown by Bglap2, Ltf and Sost downregulation (Fig
5B), iron metabolism markers were unchanged (Fig 2A), even in the presence of iron overload
conditions (Figs 1 and 2). In fact, it was possible to observe increases in bone volume fraction,
trabecular number and trabecular organization in the [C+I] group, which was unexpected
given the systemic iron overload. The main difference observed between [C+I] and [KO+I]
groups was the maintenance of bone metabolism coupling in [C+I], which was lost for [KO+I]
group. In [C+I] mice, and in clear contrast with [KO+I] mice, bone resorption parameters
were significantly downregulated, with a strong decrease in Trap positive cells and downregu-
lation of Acp5 expression. Although these mice also showed a downregulation of bone forma-
tion markers, our results suggest that the decrease in bone resorption was the main reason for
the increase in bone volume fraction and number of trabeculae detected in [C+I].
The causal mechanism for decreased osteoclast activity in [C+I] could be related with
impairment of osteocyte/osteoclast communication, due probably to increase osteocyte death
as evidenced by downregulation of Sost expression, known to affect osteoclast recruitment and
thus responsible for a downregulation of PTH/PTH1R signaling [44], in agreement with the
observed downregulation of Pth1r in the [C+I] mice (Fig 7). In addition, downregulation of
Bmp6 and Bmp2 in response to iron overload, similar to previously observed under inflamma-
tion conditions [45] (Fig 7), suggests an inhibition of BMP signaling which, together with the
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downregulation of Sost, can favor canonical WNT pathway upregulation [46] and conse-
quently negatively affect osteoclasteogenesis [47]. These results were similar to those
described for Bmpr1-KO mouse, in which inhibition of BMP signaling and repressed
expression of Sost negatively affected osteoclastogenesis resulting in increased bone for-
mation [46]. In addition, it has been shown that Trap activity can be inhibited by
increased iron exposition in vitro [48]. Altogether, these results could contribute to
explain the variability associated with bone loss phenotype in HH patients. Indeed, the
systemic nature of iron overload associated with Hfe loss of function can affect primarily
mature osteoclast activity until iron toxicity can promote generalized osteoblast death
because of the development of iron toxicity and increased oxidative stress. This could in
turn lead to an increase in osteoclastogenesis to promote bone remodeling to substitute
affected bone, consistent with what was observed in the [KO+I] group.
The iron-enriched diet induced an inflammatory response, as observed by the upregulation
of inflammatory markers like Il6 and Tnf, consistent with the induction of an osteoporotic
phenotype [41,43,49,50]. Furthermore, since the levels of inflammation are already increased
in the Hfe-KO mice [45], this could explain why the further increase resulting from iron over-
load is not significant in the [KO+I] as shown in Fig 2C.
In conclusion, our results indicate that dietary factors associated with iron overload in the
presence of HFE loss of function can promote oxidative stress and inflammation, which can be
crucial for the development of the HH-related osteoporosis.
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